Seki Y

No ORCID on file · 3 papers in corpus
2026
Multidisciplinary Trends in Endoscopic Surgery in Japan: Insights From the 17th Nationwide Survey.
Asian journal of endoscopic surgery ·doi:10.1111/ases.70302

The Japan Society for Endoscopic Surgery (JSES) conducts a nationwide survey every 2 years to evaluate the status and trends of endoscopic surgery in Japan. This article reports the results of the 17th Nationwide Survey conducted by the JSE…

rct 2021
Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results
BMC women's health ·doi:10.1186/s12905-021-01393-3

BACKGROUND: Relugolix is a once-daily, oral, nonpeptide, gonadotropin-releasing hormone receptor antagonist. The aim of this study was to evaluate safety of relugolix over 24 weeks in women with endometriosis-associated pain. METHODS: This…

article 2020
Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain in a dose–response manner: a randomized, double-blind, placebo-controlled study
Fertility and sterility ·doi:10.1016/j.fertnstert.2020.07.055

ObjectiveTo evaluate the efficacy and safety of three dose levels of relugolix, a gonadotropin-releasing hormone receptor antagonist, compared with placebo and leuprorelin in women with endometriosis-associated pain.DesignPhase 2, multicent…